Sign In
Buy STTK
$4.75
-0.120 (-2.46%)
At Close: Jun 03, 2026
Shattuck Labs, Inc. (STTK) Q4 2022 Earnings Call Transcript
10:53am, Sunday, 26'th Feb 2023
Shattuck Labs, Inc. (NASDAQ:STTK ) Q4 2022 Earnings Conference Call February 23, 2023 4:45 PM ET Company Participants Conor Richardson - Vice President, Investor Relations Taylor Schreiber - Chief Exe
Shattuck Labs to Report Fourth-Quarter and Full-Year 2022 Financial Results on February 23, 2023
07:00am, Thursday, 16'th Feb 2023
AUSTIN, TX & DURHAM, NC, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion prot
Shattuck Labs, Inc. (STTK) Q3 2022 Earnings Call Transcript
06:47am, Saturday, 12'th Nov 2022
Shattuck Labs, Inc. (NASDAQ:STTK ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Conor Richardson - Senior Director of Finance and Investor Relations Taylor Schreib
Shattuck Labs to Report Third Quarter 2022 Financial Results on November 8, 2022
04:30pm, Tuesday, 01'st Nov 2022
AUSTIN, TX and DURHAM, NC, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion pr
AUSTIN, TX & DURHAM, NC, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion prot
Should You Buy Shattuck Labs (STTK) Ahead of Earnings?
10:32am, Friday, 13'th May 2022
Shattuck Labs (STTK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Why Earnings Season Could Be Great for Shattuck Labs (STTK)
10:32am, Friday, 06'th May 2022
Shattuck Labs (STTK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Shattuck Labs to Present Two Posters at the 2022 American Association for Cancer Research (AACR) Annual Meeting
08:21am, Wednesday, 09'th Mar 2022
AUSTIN, Texas and DURHAM, N.C., March 09, 2022 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fus
Shattuck Labs Announces Participation in Upcoming 11th Annual SVB Leerink Global Healthcare Conference
05:00pm, Wednesday, 09'th Feb 2022
AUSTIN, TX and DURHAM, NC, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK ), a clinical-stage biotechnology company pioneering the development of bi-functional fusion p
Shattuck Labs Announces Participation in Upcoming January Investor Conferences
08:30am, Wednesday, 05'th Jan 2022
AUSTIN, TX and DURHAM, NC, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a
Shattuck Labs to Present at TIGIT Therapies Digital Summit 2021
07:17am, Thursday, 02'nd Dec 2021
AUSTIN, TX and DURHAM, NC, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion
Shattuck Labs Announces Participation in Upcoming November Investor Conferences
05:19pm, Wednesday, 03'rd Nov 2021
AUSTIN, TX and DURHAM, NC, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion pr
AUSTIN, TX and DURHAM, NC, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion pr
Shattuck Labs Announces Participation in Upcoming September Conferences
04:30pm, Wednesday, 01'st Sep 2021
AUSTIN, TX and DURHAM, NC, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion p
Shattuck Labs' (STTK) CEO Taylor Schreiber on Q2 2021 Results - Earnings Call Transcript
12:42am, Saturday, 14'th Aug 2021
Shattuck Labs' (STTK) CEO Taylor Schreiber on Q2 2021 Results - Earnings Call Transcript
